XML 59 R43.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount
Total stock-based compensation expense is recorded in the Consolidated Statements of Operations as follows (in thousands):
Year Ended December 31,
202520242023
Cost of revenue$425 $611 $660 
Sales and marketing7,974 10,647 12,537 
Research and development22,715 33,604 35,352 
General and administrative16,532 19,591 35,686 
Total stock-based compensation$47,646 $64,453 $84,235 
Schedule of Stock Options Roll Forward
A summary of the Company’s stock option activity under Plans for the year ended December 31, 2025 is as follows (in thousands, except weighted average information):
Number of Options OutstandingWeighted Average Exercise Price Per ShareWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
Outstanding at December 31, 2024
4,093 $2.37 2.6$19,945 
Granted— — 
Exercised(2,645)1.13 
Forfeited/Canceled(190)5.36 
Outstanding at December 31, 2025
1,258 $4.51 2.3$472 
Exercisable at December 31, 2025
1,258 $4.51 2.3$472 
Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
TrancheNumber of RSUs Eligible to VestCompany Stock Price TargetMinimum Service Period (in years)
1279,600$67.611
2279,600$82.632
3279,600$102.663
4279,600$127.704
5279,600$157.755
Schedule of Nonvested Restricted Stock Units Activity
A summary of the Company’s RSU activity for the year ended December 31, 2025 is as follows (in thousands, except weighted average information):
Number of SharesWeighted Average Grant Date Fair Value Per Share
Unvested at December 31, 2024
7,014 $14.85 
Granted4,581 5.46 
Vested(3,664)13.61 
Forfeited/Canceled(1,374)13.62 
Unvested at December 31, 2025
6,557 $9.23